Tomás Sánchez-Tamayo

Dr. Tomás Sánchez-Tamayo

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Anales de Pediatría
Verified
Journal Article
Open access
MAMaría Concepción Moreno Algarra
María Concepción Moreno Algarra
VRVerónica Fernández Romero
Verónica Fernández Romero
TSTomás Sánchez-Tamayo
Tomás Sánchez-Tamayo
MFMaría Gracia Espinosa Fernández
María Gracia Espinosa Fernández
EGEnrique Salguero García
Enrique Salguero García
Proper nutrition is one of the primary objectives in the management of preterm infants. However, lack of evidence on the best strategy to achieve this objective has led to a great variability in feeding practices. This variability may be related to the differences in the incidence of complications, such as necrotising enterocolitis (NEC). The aim of this study is to assess the variability in clinical practice regarding enteral feeding in SEN-1500 Spanish network. An observational study was conducted using a questionnaire sent out in 2013 requesting information about feeding very low birth weight (VLBW) neonates (bank milk, start time, trophic feeding, increases, fortifiers and probiotics). Responses were received from 60 of the 98 hospitals. The response rate was higher in centres with more than 50VLBW/year (30/31). Just over two-thirds (67%) have feeding protocols, and 52% refer to variability within their unit. A milk bank is available in 25% of the units. First feeding occurs fairly evenly throughout first 48hours, although it is delayed in lower gestational ages, even when there is no haemodynamic failure. In addition to hemodynamic instability there are other situations when the start is delayed (absence of breast milk, CIR, altered umbilical flow, asphyxia), while it is rarely delayed by absence of meconium or maintain an umbilical catheter.Half of those under 25 weeks begin directly with progressive increases instead of trophic feeding. Increases rarely reach 30ml/kg/day. Almost all use fortification and vitamins. There was a significant use of probiotics at the time of the survey. There is great variability in enteral nutrition policies in VLBW in Spain. Although some differences are justified by the lack of evidence, there are other interventions that have proven to be effective, such as evidence-based protocols or access to donor milk. Implementation in all the units could reduce the incidence of NEC and improve the nutritional status.

11 February 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
GSGonzalo Solis-Garcia
Gonzalo Solis-Garcia
AÁAlejandro Ávila-Álvarez
Alejandro Ávila-Álvarez
FRFermin García-Muñoz Rodrigo
Fermin García-Muñoz Rodrigo
Maximo VentoMaximo Vento
Maximo Vento
TSTomás Sánchez-Tamayo
Tomás Sánchez-Tamayo
CZCarlos Zozaya
Carlos Zozaya

1 December 2016 in Anales de Pediatría
Verified
Journal Article
Closed access
TSTomás Sánchez-Tamayo
Tomás Sánchez-Tamayo
MFMaría Gracia Espinosa Fernández
María Gracia Espinosa Fernández
LALaura Affumicato
Laura Affumicato
MLMaría González López
María González López
VRVerónica Fernández Romero
Verónica Fernández Romero
EGEnrique Salguero García
Enrique Salguero García

24 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NSNatalia Saldaña-García
Natalia Saldaña-García
MEMaría Gracia Espinosa-Fernández
María Gracia Espinosa-Fernández
JMJose David Martínez-Pajares
Jose David Martínez-Pajares
ETElías Tapia-Moreno
Elías Tapia-Moreno
MMMaría Moreno-Samos
María Moreno-Samos
TSTomás Sánchez-Tamayo
Tomás Sánchez-Tamayo
Background: Benefits of antenatal corticosteroids have been established for preterm infants who have received the full course. In imminent preterm labours there is no time to administer the second dose 24 h later. Objective: To determine whether the administration of two doses of betamethasone in a 12 h interval is equivalent to the effects of a full maturation. Methods: We performed a retrospective cohort study including preterm infants ≤34 weeks gestational age at birth and ≤1500 g, admitted to an NICU IIIC level in a tertiary hospital from 2015 to 2020. The population was divided into two cohorts: complete maturation (CM) (two doses of betamethasone 24 h apart), or advanced maturation (AM) (two doses of betamethasone 12 h apart). The primary outcomes were mortality or survival with severe morbidities. The presence of respiratory distress syndrome and other morbidities of prematurity were determined. These variables were analysed in the neonates under 28 weeks gestational age cohort. Neurodevelopment at 2 years was evaluated with the validated Ages and Stages Questionnaires®, Third Edition (ASQ®-3). Multiple regression analyses were performed and adjusted for confounding factors. Results: A total of 275 preterm neonates were included. Serious outcomes did not show differences between cohorts, no increased incidence of morbidity was found in AM. A lower percentage of hypotension during the first week (p = 0.04), a tendency towards lower maximum FiO2 (p = 0.14) and to a shorter mechanical ventilation time (p = 0.14) were observed for the AM cohort. Similar results were found in the subgroup of neonates under 28 weeks gestational age. There were no differences in cerebral palsy or sensory deficits at 24 months of corrected age, although the AM cohort showed a trend towards better scores on the ASQ3 scale. Conclusions: Administration of betamethasone every 12 h showed similar results to the traditional pattern with respect to mortality and severe morbidities. No deleterious neurodevelopmental effects were found at 24 months of corrected age. Earlier administration of betamethasone at 12 h after the first dose would be an alternative in imminent preterm delivery. Further studies are needed to confirm these results.

21 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NSNatalia Saldaña-García
Natalia Saldaña-García
MEMaría Gracia Espinosa-Fernández
María Gracia Espinosa-Fernández
CGCelia Gómez-Robles
Celia Gómez-Robles
APAntonio Javier Postigo-Jiménez
Antonio Javier Postigo-Jiménez
NBNicholas Bello
Nicholas Bello
TSTomás Sánchez-Tamayo
Tomás Sánchez-Tamayo
Background: A complete course of prenatal corticosteroids reduces the possibility of morbimortality and neonatal respiratory distress syndrome (RDS). Occasionally, it is not possible to initiate or complete the maturation regimen, and the preterm neonate is born in a non-tertiary hospital. This study aimed to assess the effects of a single dose of betamethasone within 3 h before delivery on serious outcomes (mortality and serious sequelae) and RDS in preterm neonates born in tertiary vs. non-tertiary hospitals. Materials and methods: Preterm neonates who were <35 weeks and ≤1500 g, treated during a period of five years in a level IIIC NICU, were included in this retrospective cohort study. Participants were divided into groups as follows: NM, non-matured; PM, partial maturation (one dose of betamethasone up to 3 h antepartum). They were further divided based on their place of birth (NICU-IIIC vs. non-tertiary hospitals). The morbimortality rates and the severity of neonatal RDS were evaluated. Results: A total of 76 preterm neonates were included. A decrease in serious outcomes was found in the PM group in comparison to the NM group (OR = 0.2; 95%CI (0.07–0.9)), as well as reduced need for mechanical ventilation (54% vs. 68%). The mean time between maternal admission and birth was similar in both cohorts. The mean time from the administration of betamethasone to delivery was 1 h in the PM cohort. With regard to births in NICU-IIIC, the PM group performed better in terms of serious outcomes (32% vs. 45%) and the duration of mechanical ventilation (117.75 vs. 132.18 h) compared to the NM group. In neonates born in non-tertiary hospitals with PM in comparison to the NM group, a trend towards a reduced serious outcome (28.5% vs. 62.2%) and a decreased need for mechanical ventilation (OR = 0.09; 95%CI (0.01–0.8)) and maximum FiO2 (p = 0.01) was observed. Conclusions: A single dose of betamethasone up to 3 h antepartum may reduce the rate of serious outcomes and the severity of neonatal RDS, especially in non-tertiary hospitals.

1 August 2014
Verified
Journal Article
Open access
TSTomás Sánchez-Tamayo
Tomás Sánchez-Tamayo
MFMaria G Espinosa Fernández
Maria G Espinosa Fernández
MAMaría C Moreno Algarra
María C Moreno Algarra
VRVerónica Fernández Romero
Verónica Fernández Romero
JTJose Vallejo Triano
Jose Vallejo Triano
EGEnrique Salguero García
Enrique Salguero García
The nutrition of very low birth weight (VLBW) infants is aimed at promoting a similar growth to that occurring in the uterus. However, in practice this is difficult to achieve and extrauterine growth restriction is frequent. The current tendency is to avoid this restriction by means of early parenteral and enteral nutrition. Nonetheless, uncertainty about many of the practices related with nutrition has resulted in a great variation in the way it is undertaken. In 2009 and 2011 in our hospital there was an unexpected increase in necrotizing enterocolitis. To check to see whether our nutrition policy was involved, we undertook a systematic review and drew up clinical practice guidelines (CPG) about enteral feeding in VLBW infants. New considerations about the duration of the fortification and the use of probiotics have led to an update of these CPG. A total of 21 clinical questions were designed dealing with the type of milk, starting age, mode of administration, rate and volume of the increments, fortification, use of probiotics and protocol. After conducting a systematic search of the available evidence, the information was contrasted and summarized in order to draw up the recommendations. The quality of the evidence and the strength of the recommendations were determined from the SIGN scale. These CPG aim to help physicians in their decision making. The protocolized application of well-proven measurements reduces the variation in clinical practice and improves results.